Anti-inflammatory cytokine gene therapy decreases sensory and motor dysfunction in experimental Multiple Sclerosis: MOG-EAE behavioral and anatomical symptom treatment with cytokine gene therapy. (Q41789029)
Jump to navigation
Jump to search
scientific article published on 20 September 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Anti-inflammatory cytokine gene therapy decreases sensory and motor dysfunction in experimental Multiple Sclerosis: MOG-EAE behavioral and anatomical symptom treatment with cytokine gene therapy. |
scientific article published on 20 September 2008 |
Statements
Anti-inflammatory cytokine gene therapy decreases sensory and motor dysfunction in experimental Multiple Sclerosis: MOG-EAE behavioral and anatomical symptom treatment with cytokine gene therapy (English)
Evan Sloane
A Ledeboer
W Seibert
B Coats
M van Strien
S F Maier
K W Johnson
R Chavez
L R Watkins
E D Milligan
A M Van Dam
20 September 2008
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference